Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor-Reference-Cited by-同舟云学术

Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor

Published:1999-03 Issue:1-2 Volume:95 Page:73-84
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Karachunski Peter I,Ostlie Norma S,Okita David K,Conti-Fine Bianca M

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference74 articles.

1. Functional diversity of helper T lymphocytes;Abbas;Nature,1996

2. Insulin-dependent diabetes in the NOD mouse model: II. Beta cell destruction in autoimmune diabetes is a Th2 and not a Th1 mediated event;Anderson;Autoimmunity,1993

3. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis is mediated by IL-4 and antigen-specific T cell factors;Asthana;Clin. Immunol. Immunopathol.,1993

4. Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice;Balasa;J. Exp. Med.,1997

5. The Th2 cytokine IL-4 is not required for progression of antibody-dependent autoimmune myasthenia gravis;Balasa;J. Immunol.,1998

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myasthenia Gravis and Related Disorders;The Autoimmune Diseases;2020

2. Myasthenia Gravis;Clinical Immunology;2019

3. Ginsenoside Rb1: The new treatment measure of myasthenia gravis;International Immunopharmacology;2016-12

4. A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients;Immunobiology;2016-11

5. Myasthenia Gravis and Related Disorders;The Autoimmune Diseases;2014